Earnings History Data for TG Therapeutics, Inc. (TGTX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

TG Therapeutics, Inc.

TG Therapeutics, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. The Company is focused on the development of a monoclonal antibody for the treatment of various B-cell proliferative disorders including lymphoma, leukemia, and auto-immune diseases. TG Therapeutics, Inc., formerly known as Manhattan Pharmaceuticals, Inc., is based in New York.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
04-11-2024	PM		TGTX	TG Therapeutics, Inc.	3,880	0.02	0.04	0.73	TG Therapeutics reports mixed Q3 results, provides FY outlook [11/4/2024 7:05 AM]	24.34	-2.55 (-9.50%)	24.50	-2.40 (-8.92%)	9.81 - 26.99	8,095,971	2,770,000	749,198
TG Therapeutics reports mixed Q3 results, provides FY outlook [11/4/2024 7:05 AM] TG Therapeutics signs manufacturing supply agreement with FUJIFILM Diosynth Biotechnologies [11/4/2024 11:06 AM]
01-05-2024	PM		TGTX	TG Therapeutics	2,059	-0.07	-0.03	0.00	TG Therapeutics GAAP EPS of -$0.07 misses by $0.03, revenue of $63.47M beats by $8.86M [5/1/2024 7:25 AM]	15.86	2.20 (16.07%)	17.21	3.55 (26.02%)	6.46 - 35.67	15,813,197	3,320,000	1,922,032
TG Therapeutics GAAP EPS of -$0.07 misses by $0.03, revenue of $63.47M beats by $8.86M [5/1/2024 7:25 AM] TG Therapeutics jumps as Q1 Briumvi sales top guidance [5/1/2024 9:24 AM]
01-11-2023	PM		TGTX	TG Therapeutics, Inc.	1,120	0.73	0.29	-0.26	TG Therapeutics GAAP EPS of $0.73 beats by $0.56, revenue of $165.82M beats by $102.48M [11/1/2023 7:32 AM]	10.12	2.39 (30.98%)	10.10	2.37 (30.66%)	5.16 - 35.67	46,316,620	5,610,000	3,575,165
TG Therapeutics Q3 2023 Earnings Preview [10/31/2023 1:54 PM] TG Therapeutics GAAP EPS of $0.73 beats by $0.56, revenue of $165.82M beats by $102.48M [11/1/2023 7:32 AM] TG Therapeutics gains after strong Q3 beat [11/1/2023 8:55 AM]
01-08-2023	PM		TGTX	TG Therapeutics, Inc.	2,940	-0.34	-0.26	-0.30	TG Therapeutics GAAP EPS of -$0.34 misses by $0.09, revenue of $16.07M misses by $1.88M [8/1/2023 7:57 AM]	10.48	-10.21 (-49.32%)	12.01	-8.68 (-41.95%)	4.86 - 35.67	32,894,116	3,630,000	3,853,521
TG Therapeutics GAAP EPS of -$0.34 misses by $0.09, revenue of $16.07M misses by $1.88M [8/1/2023 7:57 AM] TG Therapeutics plunges after Q2 miss [8/1/2023 9:21 AM] Biggest stock movers today: JetBlue, Nikola, TG Therapeutics and more [8/1/2023 10:26 AM]
01-05-2023	PM	7:30 AM ET (May 1)	TGTX	TG Therapeutics	3,485	-0.28	-0.36	0.00	TG Therapeutics GAAP EPS of -$0.28 beats by $0.07, revenue of $7.8M beats by $4.42M [5/1/2023 7:32 AM]	30.62	5.80 (23.34%)	25.53	0.70 (2.82%)	3.48 - 30.96	13,570,586	3,500,000	522,008
TG Therapeutics GAAP EPS of -$0.28 beats by $0.07, revenue of $7.8M beats by $4.42M [5/1/2023 7:32 AM] TG Therapeutics jumps 19% to hit 52-week high after Q1 beat (update) [5/1/2023 2:55 PM]
28-02-2023	PM	7:30 AM ET (Feb 28)	TGTX	TG Therapeutics, Inc.	2,460	-0.39	-0.26	-0.70	TG Therapeutics GAAP EPS of -$0.39 misses by $0.14, revenue of $0.08M misses by $1.52M [2/28/2023 7:32 AM]	16.16	0.23 (1.41%)	14.65	-1.28 (-8.04%)	3.48 - 19.59	3,672,763	3,870,000	116,980
TG Therapeutics Q4 2022 Earnings Preview [2/27/2023 5:55 PM] TG Therapeutics GAAP EPS of -$0.39 misses by $0.14, revenue of $0.08M misses by $1.52M [2/28/2023 7:32 AM]
10-11-2022	PM	7:30 AM ET (Nov 10)	TGTX	TG Therapeutics, Inc.	814.99	-0.26	-0.33	-0.65	TG Therapeutics GAAP EPS of -$0.26 beats by $0.07, revenue of $0.09M misses by $1.61M [11/10/2022 8:31 AM]	8.40	3.24 (62.89%)	5.76	0.60 (11.63%)	3.48 - 34.86	11,392,644	2,200,000	32,032
TG Therapeutics GAAP EPS of -$0.26 beats by $0.07, revenue of $0.09M misses by $1.61M [11/10/2022 8:31 AM] TG Therapeutics jumps 56% amid FDA labeling talks for multiple sclerosis therapy [11/10/2022 3:06 PM] TG Therapeutics Provides Business Update and Reports Third Quarter 2022 Financial Results [Nov-10-22 07:30AM] TG Therapeutics (TGTX) Reports Q3 Loss, Lags Revenue Estimates [Nov-10-22 08:45AM]
01-03-2022	PM	7:00 AM ET (Mar 1)	TGTX	TG Therapeutics, Inc.	1,420	-0.70	-0.62	-0.71	TG Therapeutics GAAP EPS of -$0.70 misses by $0.08, revenue of $2.32M beats by $0.08M [3/1/2022 7:35 AM]	10.30	0.43 (4.36%)	9.95	0.08 (0.81%)	8.04 - 51.30	1,820,173	1,720,000	480
TG Therapeutics Q4 2021 Earnings Preview [2/28/2022 12:12 PM] TG Therapeutics GAAP EPS of -$0.70 misses by $0.08, revenue of $2.32M beats by $0.08M [3/1/2022 7:35 AM] TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2021 Financial Results [Mar-01-22 07:30AM] TG Therapeutics (TGTX) Reports Q4 Loss, Lags Revenue Estimates [Mar-01-22 08:45AM]
04-11-2021	PM	7:00 AM ET (Nov 4)	TGTX	TG Therapeutics, Inc.	4,670	-0.65	-0.56	-0.73	TG Therapeutics EPS misses by $0.10, misses on revenue [11/4/2021 7:04 AM]	34.85	1.94 (5.89%)	34.85	0.0 (0.00%)	21.06 - 56.74	1,218,670	720,000	309,739
TG Therapeutics EPS misses by $0.10, misses on revenue [11/4/2021 7:04 AM] How Much Of TG Therapeutics, Inc. (NASDAQ:TGTX) Do Insiders Own? [Nov-03-21 03:17PM] TG Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results [Nov-04-21 07:00AM] TG Therapeutics Highlights Data Selected for Presentation at the 63rd American Society of Hematology (ASH) Annual Meeting [Nov-04-21 09:34AM] TG Therapeutics (TGTX) Reports Q3 Loss, Misses Revenue Estimates [Nov-04-21 08:25AM] TG Therapeutics, inc (TGTX) Q3 2021 Earnings Call Transcript [Nov-04-21 02:01PM]
02-08-2021	PM	7:00 AM ET (Aug 2)	TGTX	TG Therapeutics, Inc.	5,050	-0.59	-0.48	-0.47	TG Therapeutics EPS misses by $0.07, misses on revenue [8/2/2021 7:02 AM]	27.41	-7.58 (-21.66%)	32.48	-2.51 (-7.17%)	17.67 - 56.74	8,356,582	730,000	20,429
TG Therapeutics EPS misses by $0.07, misses on revenue [8/2/2021 7:02 AM] Exicure, Infinity Pharmaceuticals leads healthcare gainers; TG Therapeutics, Immunovant among major losers [8/2/2021 11:00 AM] TG Therapeutics sheds 20% after Q2 financials lagged expectations amid surging SG&A costs [8/2/2021 12:19 PM] TG Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results [Aug-02-21 07:00AM] TG Therapeutics (TGTX) Reports Q2 Loss, Misses Revenue Estimates [Aug-02-21 08:15AM] Here's Why TG Therapeutics Stock Is Getting Hammered Today [Aug-02-21 02:47PM]
10-05-2021	PM	7:00 AM ET (May 10)	TGTX	TG Therapeutics, Inc.	5,640	-0.69	-0.52	-0.48	TG Therapeutics EPS misses by $0.15, misses on revenue [5/10/2021 7:06 AM]	37.90	-2.30 (-5.72%)	40.77	0.57 (1.41%)	16.56 - 56.74	1,384,464	1,360,000	343
TG Therapeutics EPS misses by $0.15, misses on revenue [5/10/2021 7:06 AM] TG Therapeutics posts Q1 results, gives cash position update [5/10/2021 7:39 AM] Medical Product Stock Q1 Earnings on May 10: MRVI, TGTX & More [May-07-21 09:20AM] TG Therapeutics, Inc. to Host Earnings Call [May-10-21 06:45AM] TG Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results [May-10-21 07:00AM] TG Therapeutics (TGTX) Reports Q1 Loss, Lags Revenue Estimates [May-10-21 08:35AM]
02-03-2021	PM	4:15 PM ET (Mar 2)	TGTX	TG Therapeutics, Inc.	6,030	-0.71	-0.57	-0.38	TG Therapeutics EPS misses by $0.13, beats on revenue [3/2/2021 7:06 AM]	44.71	-0.29 (-0.64%)	45.20	0.20 (0.44%)	6.34 - 56.74	1,124,343	1,228,769	10,394
TG Therapeutics EPS misses by $0.13, beats on revenue [3/2/2021 7:06 AM] TG Therapeutics (TGTX) Reports Q4 Loss, Lags Revenue Estimates [Mar-02-21 08:35AM] TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2020 Financial Results [Mar-02-21 07:00AM] TG Therapeutics, Inc. to Host Earnings Call [Mar-02-21 06:30AM]
09-11-2020	AH	After the close (Nov 9)	TGTX	TG Therapeutics, Inc.	3,680	-0.73	-0.41	-0.67	TG Therapeutics EPS misses by $0.32, beats on revenue; outlook [11/9/2020 4:49 PM]	28.10	-0.78 (-2.72%)	27.68	-1.20 (-4.16%)	6.34 - 31.97	1,265,146	1,260,312	4,131

10-08-2020	PM	7:00 AM ET (Aug 10)	TGTX	TG Therapeutics, Inc.	2,390	-0.47	-0.31	-0.42	TG Therapeutics EPS misses by $0.13, revenue in-line [8/10/2020 7:06 AM]	18.92	-2.08 (-9.88%)	21.30	0.30 (1.43%)	4.95 - 24.76	1,967,599	1,416,102	11,021